The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Companion Diagnostics (CDx) Development Services Market Research Report 2025
Synopsis
The global Companion Diagnostics (CDx) Development Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics (CDx) Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics (CDx) Development Services.
Report Scope
The Companion Diagnostics (CDx) Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostics (CDx) Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostics (CDx) Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Segment by Type
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Segment by Application
Infectious Diseases
Neurological Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostics (CDx) Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Companion Diagnostics (CDx) Development Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics (CDx) Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics (CDx) Development Services.
Report Scope
The Companion Diagnostics (CDx) Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostics (CDx) Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostics (CDx) Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Segment by Type
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Segment by Application
Infectious Diseases
Neurological Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostics (CDx) Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Feasibility Studies
1.2.3 Assay Development
1.2.4 Analytical Validation
1.2.5 Clinical Validation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostics (CDx) Development Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Diseases
1.3.3 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2019-2030)
2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region
2.2.1 Global Companion Diagnostics (CDx) Development Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2019-2024)
2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2025-2030)
2.3 Companion Diagnostics (CDx) Development Services Market Dynamics
2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends
2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers
2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges
2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue
3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2019-2024)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue
3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio
3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2023
3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type
4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2019-2024)
4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2025-2030)
5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application
5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2019-2024)
5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2019-2030)
6.2 North America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)
6.4 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2019-2030)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)
7.4 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2019-2030)
8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2019-2030)
9.2 Latin America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)
9.4 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2019-2030)
10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Detail
11.1.2 Geneuity-Clinical Research Services Business Overview
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction
11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.1.5 Geneuity-Clinical Research Services Recent Development
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Detail
11.2.2 Interpace Biosciences Business Overview
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction
11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.2.5 Interpace Biosciences Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction
11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.3.5 Labcorp Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction
11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 Q² Solutions
11.5.1 Q² Solutions Company Detail
11.5.2 Q² Solutions Business Overview
11.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Introduction
11.5.4 Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.5.5 Q² Solutions Recent Development
11.6 ResearchDx
11.6.1 ResearchDx Company Detail
11.6.2 ResearchDx Business Overview
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction
11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.6.5 ResearchDx Recent Development
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Detail
11.7.2 Almac Diagnostic Services Business Overview
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction
11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.7.5 Almac Diagnostic Services Recent Development
11.8 Biocartis
11.8.1 Biocartis Company Detail
11.8.2 Biocartis Business Overview
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction
11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.8.5 Biocartis Recent Development
11.9 Cerba Research
11.9.1 Cerba Research Company Detail
11.9.2 Cerba Research Business Overview
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction
11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.9.5 Cerba Research Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction
11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.10.5 Eurofins Scientific Recent Development
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Detail
11.11.2 MLM Medical Labs Business Overview
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction
11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.11.5 MLM Medical Labs Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction
11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.12.5 Qiagen Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction
11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.13.5 BGI Genomics Recent Development
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Detail
11.14.2 MEDx Translational Medicine Business Overview
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction
11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.14.5 MEDx Translational Medicine Recent Development
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Detail
11.15.2 Medical Biological Laboratories (MBL) Business Overview
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction
11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.15.5 Medical Biological Laboratories (MBL) Recent Development
11.16 Novogene
11.16.1 Novogene Company Detail
11.16.2 Novogene Business Overview
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction
11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)
11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Feasibility Studies
Table 3. Key Players of Assay Development
Table 4. Key Players of Analytical Validation
Table 5. Key Players of Clinical Validation
Table 6. Key Players of Others
Table 7. Global Companion Diagnostics (CDx) Development Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2019-2024)
Table 11. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2025-2030)
Table 13. Companion Diagnostics (CDx) Development Services Market Trends
Table 14. Companion Diagnostics (CDx) Development Services Market Drivers
Table 15. Companion Diagnostics (CDx) Development Services Market Challenges
Table 16. Companion Diagnostics (CDx) Development Services Market Restraints
Table 17. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Companion Diagnostics (CDx) Development Services Market Share by Players (2019-2024)
Table 19. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2023)
Table 20. Ranking of Global Top Companion Diagnostics (CDx) Development Services Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Companion Diagnostics (CDx) Development Services Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
Table 24. Date of Enter into Companion Diagnostics (CDx) Development Services Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2019-2024)
Table 28. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2025-2030)
Table 30. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2019-2024)
Table 32. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2025-2030)
Table 34. North America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 49. Geneuity-Clinical Research Services Company Detail
Table 50. Geneuity-Clinical Research Services Business Overview
Table 51. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product
Table 52. Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 53. Geneuity-Clinical Research Services Recent Development
Table 54. Interpace Biosciences Company Detail
Table 55. Interpace Biosciences Business Overview
Table 56. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product
Table 57. Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 58. Interpace Biosciences Recent Development
Table 59. Labcorp Company Detail
Table 60. Labcorp Business Overview
Table 61. Labcorp Companion Diagnostics (CDx) Development Services Product
Table 62. Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 63. Labcorp Recent Development
Table 64. Quest Diagnostics Company Detail
Table 65. Quest Diagnostics Business Overview
Table 66. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product
Table 67. Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 68. Quest Diagnostics Recent Development
Table 69. Q² Solutions Company Detail
Table 70. Q² Solutions Business Overview
Table 71. Q² Solutions Companion Diagnostics (CDx) Development Services Product
Table 72. Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 73. Q² Solutions Recent Development
Table 74. ResearchDx Company Detail
Table 75. ResearchDx Business Overview
Table 76. ResearchDx Companion Diagnostics (CDx) Development Services Product
Table 77. ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 78. ResearchDx Recent Development
Table 79. Almac Diagnostic Services Company Detail
Table 80. Almac Diagnostic Services Business Overview
Table 81. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product
Table 82. Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 83. Almac Diagnostic Services Recent Development
Table 84. Biocartis Company Detail
Table 85. Biocartis Business Overview
Table 86. Biocartis Companion Diagnostics (CDx) Development Services Product
Table 87. Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 88. Biocartis Recent Development
Table 89. Cerba Research Company Detail
Table 90. Cerba Research Business Overview
Table 91. Cerba Research Companion Diagnostics (CDx) Development Services Product
Table 92. Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 93. Cerba Research Recent Development
Table 94. Eurofins Scientific Company Detail
Table 95. Eurofins Scientific Business Overview
Table 96. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product
Table 97. Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 98. Eurofins Scientific Recent Development
Table 99. MLM Medical Labs Company Detail
Table 100. MLM Medical Labs Business Overview
Table 101. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product
Table 102. MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 103. MLM Medical Labs Recent Development
Table 104. Qiagen Company Detail
Table 105. Qiagen Business Overview
Table 106. Qiagen Companion Diagnostics (CDx) Development Services Product
Table 107. Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 108. Qiagen Recent Development
Table 109. BGI Genomics Company Detail
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Companion Diagnostics (CDx) Development Services Product
Table 112. BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. MEDx Translational Medicine Company Detail
Table 115. MEDx Translational Medicine Business Overview
Table 116. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product
Table 117. MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 118. MEDx Translational Medicine Recent Development
Table 119. Medical Biological Laboratories (MBL) Company Detail
Table 120. Medical Biological Laboratories (MBL) Business Overview
Table 121. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product
Table 122. Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 123. Medical Biological Laboratories (MBL) Recent Development
Table 124. Novogene Company Detail
Table 125. Novogene Business Overview
Table 126. Novogene Companion Diagnostics (CDx) Development Services Product
Table 127. Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)
Table 128. Novogene Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Companion Diagnostics (CDx) Development Services Market Share by Type: 2023 VS 2030
Figure 3. Feasibility Studies Features
Figure 4. Assay Development Features
Figure 5. Analytical Validation Features
Figure 6. Clinical Validation Features
Figure 7. Others Features
Figure 8. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2023 VS 2030
Figure 10. Infectious Diseases Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Companion Diagnostics (CDx) Development Services Report Years Considered
Figure 13. Global Companion Diagnostics (CDx) Development Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Companion Diagnostics (CDx) Development Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Companion Diagnostics (CDx) Development Services Market Share by Region: 2023 VS 2030
Figure 16. Global Companion Diagnostics (CDx) Development Services Market Share by Players in 2023
Figure 17. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2023
Figure 19. North America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)
Figure 21. United States Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)
Figure 25. Germany Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Share by Region (2019-2030)
Figure 33. China Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)
Figure 41. Mexico Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)
Figure 45. Turkey Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Geneuity-Clinical Research Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 48. Interpace Biosciences Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 49. Labcorp Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 50. Quest Diagnostics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 51. Q² Solutions Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 52. ResearchDx Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 53. Almac Diagnostic Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 54. Biocartis Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 55. Cerba Research Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 56. Eurofins Scientific Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 57. MLM Medical Labs Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 58. Qiagen Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 59. BGI Genomics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 60. MEDx Translational Medicine Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 61. Medical Biological Laboratories (MBL) Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 62. Novogene Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
